GeneTex

  • Country / Location Selection

United States (US)

KALRN blocking peptide

Cat. No. GTX89287-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89287.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-RWHLGPGDPFSTYV

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Kalirin Rhogef Kinase , Arhgef24 , Chd5 , Chds5 , Duet , Duo , Hapip , Trad , Kalrn

Background

Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for KALRN blocking peptide (GTX89287-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for KALRN blocking peptide (GTX89287-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239